SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales is pegged at Rs. 19081.70 millions for the March 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 24950.30 millions during the year-ago period.The Net Profit of the company slipped to Rs. 3187.90 millions from Rs. 8829.60 millions, a decline of -63.90% on QoQ basis.Operating profit for the quarter ended March 2023 decreased to 5548.50 millions as compared to 11464.80 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 19081.70 24950.30 -23.52 76253.00 88798.20 -14.13 76253.00 88798.20 -14.13
Other Income 661.50 505.10 30.96 3490.10 1112.60 213.69 3490.10 1112.60 213.69
PBIDT 5548.50 11464.80 -51.60 26966.90 39877.20 -32.38 26966.90 39877.20 -32.38
Interest 1.80 0.40 350.00 5.20 6.50 -20.00 5.20 6.50 -20.00
PBDT 5546.70 11464.40 -51.62 26961.70 39870.70 -32.38 26961.70 39870.70 -32.38
Depreciation 866.30 807.50 7.28 3420.70 3105.50 10.15 3420.70 3105.50 10.15
PBT 4680.40 10656.90 -56.08 23541.00 36765.20 -35.97 23541.00 36765.20 -35.97
TAX 1492.50 1827.30 -18.32 5459.50 7279.80 -25.00 5459.50 7279.80 -25.00
Deferred Tax 437.40 380.40 14.98 1083.70 907.80 19.38 1083.70 907.80 19.38
PAT 3187.90 8829.60 -63.90 18081.50 29485.40 -38.68 18081.50 29485.40 -38.68
Equity 530.90 530.90 0.00 530.90 530.90 0.00 530.90 530.90 0.00
PBIDTM(%) 29.08 45.95 -36.72 35.37 44.91 -21.25 35.37 44.91 -21.25

Divis Lab Share Price

6228.95 -68.55 (-1.09%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×